20/04/2026Published by Fondazione Gianni Bonadonna at 20/04/2026Categories Events UncategorizedZanidatamab in HER2- positive metastatic biliary tract cancer
13/04/2026Published by Fondazione Gianni Bonadonna at 13/04/2026Categories Events UncategorizedA comparison of mFOLFRINOX versus PAXG in pancreatic ductal adenocarcinoma
30/03/2026Published by Fondazione Gianni Bonadonna at 30/03/2026Categories Events UncategorizedPalbociclib added to anti-HER2 and endocrine therapies in advanced breast cancer. Results from the PATINA study
23/03/2026Published by Fondazione Gianni Bonadonna at 23/03/2026Categories Events UncategorizedNeoadjuvant ipilimumab plus nivolumab in melanoma
16/03/2026Published by Fondazione Gianni Bonadonna at 16/03/2026Categories Events UncategorizedAnbenitamab in previously treated HER2-positive gastric cancer
09/03/2026Published by Fondazione Gianni Bonadonna at 09/03/2026Categories Events UncategorizedTargeted immunocytokines as a neoadjuvant treatment in melanoma
02/03/2026Published by Fondazione Gianni Bonadonna at 02/03/2026Categories Events UncategorizedNeoadjuvant camrelizumab plus chemotherapy in triple-negative breast cancer
23/02/2026Published by Fondazione Gianni Bonadonna at 23/02/2026Categories Events UncategorizedCamrelizumab plus chemotherapy as neoadjuvant therapy in resectable esophageal squamous cell carcinoma
16/02/2026Published by Fondazione Gianni Bonadonna at 16/02/2026Categories Events UncategorizedA combination of nivolumab and ipilimumab in noncolorectal cancers
